Recently public life sciences company, Wesana Health (WESA), is set to acquire Psytech Inc. for $21 million CAD in Wesana Health stock. Announcing the news today, Wesana said that Psytech will help contribute to its research of using psilocybin therapy to treat Traumatic Brain Injury (TBI). Psytech’s current business model includes Tovana Solutions, a clinical…